Charnwood Molecular is an award-winning UK Contract Research Organisation with over 20 years of experience in supporting pharmaceuticals and biotechnology. Their goal is to add significant value to your project by fully leveraging their expertise and achieving consistent excellence in research. They offer a wide range of products and services in the field of drug discovery, including integrated drug discovery, target validation, assay development, hit identification, hit to lead, and lead optimization.

Their expertise also extends to various therapeutic areas such as oncology, inflammation & immunology, central nervous system, metabolic diseases, respiratory diseases, infectious diseases, and rare/orphan diseases. Charnwood Molecular's capabilities encompass bioscience, medicinal chemistry, computational chemistry, analytical chemistry, and DMPK (drug metabolism and pharmacokinetics)/ADME (absorption, distribution, metabolism, and excretion). They also provide chemical development services to support the pre-clinical development of drug candidates.

With their dedication to innovation and problem-solving, Charnwood Molecular is committed to helping clients achieve their milestones and business objectives on time and within budget